Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.

Dai L, King DW, Perera DS, Lubowski DZ, Burcher E, Liu L.

Dig Dis Sci. 2015 May;60(5):1236-46. doi: 10.1007/s10620-014-3478-7. Epub 2015 Feb 11.

PMID:
25666316
2.

ATP during early bladder stretch is important for urgency in detrusor overactivity patients.

Cheng Y, Mansfield KJ, Allen W, Chess-Williams R, Burcher E, Moore KH.

Biomed Res Int. 2014;2014:204604. doi: 10.1155/2014/204604. Epub 2014 May 27.

3.

Gene expression of muscarinic, tachykinin, and purinergic receptors in porcine bladder: comparison with cultured cells.

Bahadory F, Moore KH, Liu L, Burcher E.

Front Pharmacol. 2013 Nov 28;4:148. doi: 10.3389/fphar.2013.00148. eCollection 2013.

4.

Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.

Cheng Y, Mansfield KJ, Allen W, Millard RJ, Burcher E, Moore KH.

Neurourol Urodyn. 2013 Sep;32(7):969-73. doi: 10.1002/nau.22344. Epub 2012 Nov 5.

PMID:
23129360
5.

Acid and stretch, but not capsaicin, are effective stimuli for ATP release in the porcine bladder mucosa: Are ASIC and TRPV1 receptors involved?

Sadananda P, Kao FC, Liu L, Mansfield KJ, Burcher E.

Eur J Pharmacol. 2012 May 15;683(1-3):252-9. doi: 10.1016/j.ejphar.2012.02.041. Epub 2012 Mar 7.

PMID:
22421400
6.

Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase.

Dai L, Perera DS, King DW, Southwell BR, Burcher E, Liu L.

J Pharmacol Exp Ther. 2012 Jan;340(1):27-36. doi: 10.1124/jpet.111.186155. Epub 2011 Sep 28.

PMID:
21957267
7.

Porcine bladder urothelial, myofibroblast, and detrusor muscle cells: characterization and ATP release.

Cheng Y, Mansfield KJ, Sandow SL, Sadananda P, Burcher E, Moore KH.

Front Pharmacol. 2011 Jun 7;2:27. doi: 10.3389/fphar.2011.00027. eCollection 2011.

8.

Immunocytochemical characterisation of cultures of human bladder mucosal cells.

Woodman JR, Mansfield KJ, Lazzaro VA, Lynch W, Burcher E, Moore KH.

BMC Urol. 2011 Apr 18;11:5. doi: 10.1186/1471-2490-11-5.

9.

Distinct differences in tachykinin gene expression in ulcerative colitis, Crohn's disease and diverticular disease: a role for hemokinin-1?

Liu L, Markus I, Saghire HE, Perera DS, King DW, Burcher E.

Neurogastroenterol Motil. 2011 May;23(5):475-83, e179-80. doi: 10.1111/j.1365-2982.2011.01685.x. Epub 2011 Feb 22.

PMID:
21342363
10.

Complex actions of neurotensin in ascending and sigmoid colonic muscle: Involvement of enteric mediators.

Azriel Y, Liu L, Burcher E.

Eur J Pharmacol. 2010 Oct 10;644(1-3):195-202. doi: 10.1016/j.ejphar.2010.06.049. Epub 2010 Jul 6. Erratum in: Eur J Pharmacol. 2011 Jan 15;650(2-3):708. Bucher, Elizabeth [corrected to Burcher, Elizabeth].

PMID:
20615399
11.

Localization of muscarinic receptors M1R, M2R and M3R in the human colon.

Harrington AM, Peck CJ, Liu L, Burcher E, Hutson JM, Southwell BR.

Neurogastroenterol Motil. 2010 Sep;22(9):999-1008, e262-3. doi: 10.1111/j.1365-2982.2009.01456.x. Epub 2010 Feb 9.

PMID:
20146726
12.

Does adenosine triphosphate released into voided urodynamic fluid contribute to urgency signaling in women with bladder dysfunction?

Cheng Y, Mansfield KJ, Allen W, Walsh CA, Burcher E, Moore KH.

J Urol. 2010 Mar;183(3):1082-6. doi: 10.1016/j.juro.2009.11.028. Epub 2010 Jan 21.

PMID:
20092837
13.

Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretch.

Sadananda P, Shang F, Liu L, Mansfield KJ, Burcher E.

Br J Pharmacol. 2009 Dec;158(7):1655-62. doi: 10.1111/j.1476-5381.2009.00431.x.

14.

Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation.

Liu L, Shang F, Morgan MJ, King DW, Lubowski DZ, Burcher E.

J Pharmacol Exp Ther. 2009 Apr;329(1):282-9. doi: 10.1124/jpet.108.148148. Epub 2009 Jan 22.

PMID:
19164461
15.

Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.

Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E.

J Pharmacol Exp Ther. 2009 Mar;328(3):893-9. doi: 10.1124/jpet.108.145508. Epub 2008 Nov 24.

PMID:
19029429
16.

Contractile properties of the pig bladder mucosa in response to neurokinin A: a role for myofibroblasts?

Sadananda P, Chess-Williams R, Burcher E.

Br J Pharmacol. 2008 Apr;153(7):1465-73. doi: 10.1038/bjp.2008.29. Epub 2008 Feb 11.

17.

Tachykinin NK2 receptor and functional mechanisms in human colon: changes with indomethacin and in diverticular disease and ulcerative colitis.

Burcher E, Shang F, Warner FJ, Du Q, Lubowski DZ, King DW, Liu L.

J Pharmacol Exp Ther. 2008 Jan;324(1):170-8. Epub 2007 Oct 24.

PMID:
17959748
18.
19.

Age-related changes of P2X(1) receptor mRNA in the bladder detrusor from men with and without bladder outlet obstruction.

Chua WC, Liu L, Mansfield KJ, Vaux KJ, Moore KH, Millard RJ, Burcher E.

Exp Gerontol. 2007 Jul;42(7):686-92. Epub 2007 Feb 20.

PMID:
17399929
20.

The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.

Liu L, Mansfield KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E.

Neurourol Urodyn. 2007;26(3):433-8; discussion 439; discussion 451-3.

PMID:
17016800
21.

Tachykinin peptides and receptors: putting amphibians into perspective.

Liu L, Burcher E.

Peptides. 2005 Aug;26(8):1369-82. Epub 2005 Apr 21. Review.

PMID:
16042977
22.
23.

Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.

Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E.

Br J Pharmacol. 2005 Apr;144(8):1089-99.

24.
25.

Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.

Johansson A, Liu L, Holmgren S, Burcher E.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Jul;370(1):35-45. Epub 2004 Jul 2.

PMID:
15235762
26.

Molecular identification and characterization of three isoforms of tachykinin NK(1)-like receptors in the cane toad Bufo marinus.

Liu L, Markus I, Vandenberg RJ, Neilan BA, Murray M, Burcher E.

Am J Physiol Regul Integr Comp Physiol. 2004 Sep;287(3):R575-85. Epub 2004 May 20.

27.

Muscarinic receptor subtypes in the human colon: lack of evidence for atypical subtypes.

Mansfield KJ, Mitchelson FJ, Moore KH, Burcher E.

Eur J Pharmacol. 2003 Dec 15;482(1-3):101-9.

PMID:
14660010
28.

Human tachykinin NK2 receptor: a comparative study of the colon and urinary bladder.

Warner FJ, Miller RC, Burcher E.

Clin Exp Pharmacol Physiol. 2003 Sep;30(9):632-9.

PMID:
12940880
29.
30.

Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease.

Liu L, Shang F, Markus I, Burcher E.

J Pharmacol Exp Ther. 2002 Aug;302(2):627-35.

PMID:
12130725
31.
33.

Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.

Lee CM, Kumar RK, Lubowski DZ, Burcher E.

Dig Dis Sci. 2002 Mar;47(3):495-502.

PMID:
11913410
34.
36.
37.

Radioligand binding and functional characterisation of tachykinin receptors in chicken small intestine.

Liu L, Burcher E.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Oct;364(4):305-13.

PMID:
11683517
38.

Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon.

Azriel Y, Burcher E.

J Pharmacol Exp Ther. 2001 Jun;297(3):1074-81.

PMID:
11356931
39.
40.

Bufokinin: immunoreactivity, receptor localization and actions in toad intestine and mesenteric circulation.

Liu L, Shang F, Perry MA, Comis A, Burcher E.

Peptides. 2000 Sep;21(9):1345-54.

PMID:
11072121
41.

Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colon.

Warner FJ, Liu L, Lubowski DZ, Burcher E.

Clin Exp Pharmacol Physiol. 2000 Nov;27(11):928-33.

PMID:
11071312
42.

Bufokinin: actions and distribution in the toad cardiovascular system.

Liu L, Shang F, Comis A, Burcher E.

Clin Exp Pharmacol Physiol. 2000 Nov;27(11):911-6.

PMID:
11071309
43.

Angiotensin II in child urinary bladder: functional and autoradiographic studies.

Lam DS, Dias LS, Moore KH, Burcher E.

BJU Int. 2000 Sep;86(4):494-501.

44.

Binding characteristics of endothelin ET(A) receptors in normal and post-mortem rat lung.

Dias LS, Schell DN, Burcher E.

Peptides. 2000 Jun;21(6):861-9.

PMID:
10959009
45.
46.

Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder.

Burcher E, Zeng XP, Strigas J, Shang F, Millard RJ, Moore KH.

J Urol. 2000 Jan;163(1):331-7.

PMID:
10604385
47.

Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of origin.

Liu L, Warner FJ, Conlon JM, Burcher E.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Aug;360(2):187-95.

PMID:
10494889
48.

Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.

Warner FJ, Comis A, Miller RC, Burcher E.

Br J Pharmacol. 1999 Jul;127(5):1105-10.

49.
50.

Binding and functional potency of neurokinin A analogues in the rat fundus: A structure-activity study.

Matuszek MA, Comis A, Burcher E.

Pharmacology. 1999 May;58(5):227-35.

PMID:
10087463

Supplemental Content

Loading ...
Support Center